|Last Price$14.67||Day Change (%)2.44%|
|Open Price$14.55||Day Change ($)0.35|
|Day Range14.21–14.82||52-Week Range10.10–15.34|
As of Fri 11/21/2014 05:17 PM EST | USD
Research and Markets: Global Cervical Cancer Therapeutic Pipeline Review, H2 2014 - 35 Companies & 71 Drug Profiles
Research and Markets: Cancer Pain Therapeutics Pipeline Report 2014 - 30 Companies & 43 Drug Profiles
Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets
Three ways to separate long-term winners from stocks that fizzle.